CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2033-06-06 | Walsh Kathleen E Director | Grant or award · Stock Option (Right to Buy) | +16,532 | 16,532 | ||
| 2026-10-16 | Evans John M. CEO | Option exercise 10b5-1 | +25,000 | $1.03 | $26K | 1,072,205 |
| 2026-10-16 | Evans John M. CEO | Sale 10b5-1 | −25,000 | $23.98 | $600K | 1,047,205 |
| 2026-10-16 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 155,804 | ||
| 2026-10-15 | Evans John M. CEO | Option exercise 10b5-1 | +25,000 | $1.03 | $26K | 1,072,205 |
| 2026-10-15 | Evans John M. CEO | Sale 10b5-1 | −25,000 | $23.57 | $589K | 1,047,205 |
| 2026-10-15 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 180,804 | ||
| 2026-10-01 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −187 | $24.41 | $5K | 50,984 |
| 2026-09-24 | Ciaramella Giuseppe President | Gift | −123,407 | 130,504 | ||
| 2026-07-27 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −16,667 | $25.74 | $429K | 85,696 |
| 2026-06-30 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −373 | $34.73 | $13K | 102,363 |
| 2026-06-30 | Evans John M. CEO | Option exercise 10b5-1 | +25,000 | $1.03 | $26K | 1,072,205 |
| 2026-06-30 | Evans John M. CEO | Sale 10b5-1 | −23,100 | $34.26 | $791K | 1,049,105 |
| 2026-06-30 | Evans John M. CEO | Sale 10b5-1 | −1,900 | $34.84 | $66K | 1,047,205 |
| 2026-06-30 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 205,804 | ||
| 2026-06-29 | Evans John M. CEO | Option exercise 10b5-1 | +18,663 | $0.67 | $13K | 1,065,868 |
| 2026-06-29 | Evans John M. CEO | Option exercise 10b5-1 | +6,337 | $1.03 | $7K | 1,072,205 |
| 2026-06-29 | Evans John M. CEO | Sale 10b5-1 | −13,421 | $35.13 | $472K | 1,058,784 |
| 2026-06-29 | Evans John M. CEO | Sale 10b5-1 | −11,579 | $35.91 | $416K | 1,047,205 |
| 2026-06-29 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,663 | 9 |
Page 1 of 32 · 630 trades